Home » AMT Appoints New Chief Executive Officer
AMT Appoints New Chief Executive Officer
March 10, 2005
Amsterdam Molecular Therapeutics (AMT) announced the appointment of Ronald Lorijn as chief executive officer. Lorijn replaces Jan Boesen, who left AMT on March 1, 2005.
PharmaLive (http://www.medadnews.com/News/Index.cfm?articleid=219263)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
21Oct